基于广泛结合T细胞表位的HIV疫苗在非人灵长类中诱导广泛多功能T细胞反应并提供冗余人群HLA II类覆盖
研究评估DNA疫苗HIVBr18编码的18个保守广泛结合表位与34种人类II类HLA分子的结合,并在恒河猴中经体内电穿孔免疫。结果显示多个肽段实现100%冗余人群覆盖,所有动物对18个表位中的13个诱导以多功能CD4+ T细胞为主的强反应,每只动物T细胞识别7-11个表位。
要点
- HIVBr18编码的18个表位中多个肽段对34种II类HLA分子实现100%冗余人群覆盖。
- 恒河猴免疫后所有动物对18个表位中的13个产生强多功能CD4+ T细胞反应,每只识别7-11个表位。
- 结果提供初步概念验证:高冗余人群覆盖表位疫苗可跨物种和MHC屏障诱导强T细胞反应。
核心结论
- 免疫编码高冗余人群覆盖表位的疫苗可跨物种和MHC屏障诱导针对多个表位的强T细胞反应,为快速部署诱导细胞免疫的免疫原提供初步概念验证。
研究设计与样本
- 生物信息学鉴定表位构建DNA疫苗HIVBr18,评估其表位与34种人类II类HLA(HLA-DR、DQ、DP)分子的结合,并在恒河猴中经体内电穿孔免疫。
主要发现
- 多个肽段实现对人类人群的100%冗余覆盖。
- 所有免疫动物对18个表位中的13个诱导强且以多功能CD4+ T细胞为主的反应,每只动物T细胞识别7-11个表位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the last few decades, several emerging or reemerging viral diseases with no readily available vaccines have ravaged the world. A platform to fastly generate vaccines inducing potent and durable neutralizing antibody and T cell responses is sorely needed. Bioinformatically identified epitope-based vaccines can focus on immunodominant T cell epitopes and induce more potent immune responses than a whole antigen vaccine and may be deployed more rapidly and less costly than whole-gene vaccines. Increasing evidence has shown the importance of the CD4+ T cell response in protection against HIV and other viral infections. The previously described DNA vaccine HIVBr18 encodes 18 conserved, promiscuous epitopes binding to multiple HLA-DR-binding HIV epitopes amply recognized by HIV-1-infected patients. HIVBr18 elicited broad, polyfunctional, and durable CD4+and CD8+ T cell responses in BALB/c and mice transgenic to HLA class II alleles, showing cross-species promiscuity. To fully delineate the promiscuity of the HLA class II vaccine epitopes, we assessed their binding to 34 human class II (HLA-DR, DQ, and -DP) molecules, and immunized nonhuman primates. Results ascertained redundant 100% coverage of the human population for multiple peptides. We then immunized Rhesus macaques with HIVBr18 under in vivo electroporation. The immunization induced strong, predominantly polyfunctional CD4+ T cell responses in all animals to 13 out of the 18 epitopes; T cells from each animal recognized 7-11 epitopes. Our results provide a preliminary proof of concept that immunization with a vaccine encoding epitopes with high and redundant coverage of the human population can elicit potent T cell responses to multiple epitopes, across species and MHC barriers. This approach may facilitate the rapid deployment of immunogens eliciting cellular immunity against emerging infectious diseases, such as COVID-19.
引用
- Ribeiro SP, De Moura Mattaraia VG, Almeida RR, et al. A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates. Vaccine. 2021. PMID: 34961636. doi:10.1016/j.vaccine.2021.11.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。